Congress has a chance to close the FDA’s Theranos loophole; CMS chief: ‘Door is really open’ on Alzheimer’s drugs coverage

Right now, tests developed in clinical labs don't undergo the same scrutiny as tests developed by big, commercial test companies. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: Congress has a chance to close the FDA's Theranos loophole By Rachel Cohrs and Sarah Owermohle Justin Sullivan/Getty Images Right now, tests developed in clinical labs don’t undergo the same scrutiny as tests developed by big, commercial test companies. Read More STAT+: Medicare chief: 'Door is really open' on coverage for new Alzheimer's drug By Bob Herman Chip Somodevilla/Getty Images Medicare is willing to reevaluate its coverage of Alzheimer’s drugs in light of a new therapy, called lecanemab, the CMS director said. Read More Jynneos mpox vaccine provided strong protection against infection, new CDC data show By Helen Branswell Mario Tama/Getty Images People who received one or two doses of mpox vaccine contracted the infection at substantially lower rates than unvaccinated people. Read More Sponsored Insight by NOVAVAX How is Novavax helping to provide enhanced immunity with its vaccine technology? Novavax uses a naturally derived saponin ingredient in its vaccine technology. This proprietary adjuvant was developed with the goal of stimulating an enhanced immune response. Learn more. FDA authorizes updated Covid-19 boosters for youngest children By Helen Branswell JOSEPH PREZIOSO/AFP via Getty Images Previously, the bivalent boosters, which protect against two different strains of the SARS-CoV-2 virus, were available to kids 5 and older. Read More Amid criticism, Stanford turns over review of its president to outside investigator By Damian Garde Cindy Ord/Getty Images for World Science Festival Mark Filip, a former federal judge, will lead the investigation into Stanford president Marc Tessier-Lavigne. Read More STAT+: Mark Cuban teams with a business coalition in bid to lower drug costs for employers By Ed Silverman Kris Connor/Getty Images for A+E Networks The goal is to offer employers a new option for prescription drugs while also capturing much of the same data that may be lost to GoodRx. Read More Walensky says CDC needs more authority from Congress to collect public health data By Rachel Cohrs Milken Institute The CDC needs Congress to help it collect more data from state, local, and tribal public health departments, Director Rochelle Walensky said. Read More Opinion: If you think health care is dysfunctional now, just wait until after January 1 By Greg Jasani Adobe Medicare's proposed cuts to physician pay will limit access to primary care and create a surge in visits to emergency departments. Read More The 'electric vehicles' of pharma, Illumina's boondoggle, & a Theranos sentencing By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Elaine Chen joins us to explain how the escalating demand for a diabetes drug is putting people with obesity in a difficult situation. Read More Thursday, December 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser